Skip to content

CROI: Region of origin and gender significant in long-term changes in CD4 cell count during effective HIV therapy

CROI: Recreational drug use a risk for asymptomatic heart disorders in HIV-positive patients

CROI: Once daily Kaletra tablets non-inferior to twice daily dose

CROI: HAART Breastfeeding study detects drug resistance in HIV-infected infants

CROI: Large cohorts show excellent responses to ART in developing countries

CROI: Untreated HIV-positive individuals have a higher risk of death even at CD4 counts over 350

CROI: Delaying HAART while treating opportunistic infections increases the risk of disease progression and death

CROI: Biomarker changes may help explain detrimental effects of treatment interruption

CROI: Nanoparticle technology creates a once-a-month HIV drug